PVSRIPO enters cells via the poliovirus receptor, CD155, which is ectopically expressed in virtually all solid neoplasias [16–20], except possibly Burkitt lymphoma (where EBV infection interferes with CD155 upregulation [21]), including breast and prostate cancers [22, 23]. This evidence concerns the gene PVR and prostate carcinoma.